Publications & Resources

A new edition of The Albany Report helps policyholders understand the impact of the recent expansion of the medical malpractice statute of limitations in New York State.

The new edition of The Albany Report includes updates on statute of limitations legislation, tort reform and Governor Cuomo’s executive budget.

In December 2017, New York State became the first in the nation to require that new registered nurses earn a baccalaureate degree or higher within 10 years of licensure. The new educational requirement does not affect nurses who are already in practice.

Senate Bill S1869A amends New York State Public Health Law to allow attending nurse practitioners (NPs) to sign Do Not Resuscitate (DNR) orders and Medical Orders for Life-Sustaining Treatment (MOLST).

Effective October 5, 2017, the Department of Health adopted an emergency regulation to allow certain types of facilities to become designated caregivers for patients who are certified to receive medical marijuana under New York State’s Medical Marijuana Program.

NYS Department of Health (DOH) regulations allow patients to self-administer medical marijuana in the facility during their hospital stay. Facilities that allow patients to self-administer any medications should ensure that all aspects of the regulation are included in their policies and procedures.

The newest edition of The Albany Report arrives on the heels of a NYS legislative session that included some surprises and disappointments for the medical malpractice insurance market.

As the New York State Legislature enters the second half of the 2017 legislative session, MLMIC has released a second issue of The Albany Report.

A new MLMIC publication, The Albany Report, is intended to enhance this advocacy by providing policyholders with a concise, insiders’ view of pending legislative, regulatory and political developments that have an impact on the NYS medical malpractice insurance marketplace.

New York State requires all narcotic prescribers to attend three hours of continuing medical education (CME) that address specifically designated aspects of prescribing controlled substances. These CMEs must be completed prior to July 1, 2017.